Myriad Genetics Inc. (MYGN)
Market Closed
10 Sep, 20:00
$
3. 36
+0.17
+5.3292%
Pre Market
$
+0.04 +1.1905% 3. 40
301.29M Market Cap
- P/E Ratio
- Div Yield
3.94M Volume
-0.35 Eps
$ 3.19
Previous Close 
Want to track MYGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Myriad Genetics Inc. (MYGN) Statistics
Valuation metrics
Market Cap 301.29M
Enterprise value 396.59M
Trailing P/E (ttm) -2.67
Forward P/E 23.88
PEG ratio -0.04
Price/Sales (ttm) 0.37
Price/Book (mrq) 1
Enterprise Value/Revenue 0.49
Enterprise Value/EBITDA -8.77
Overview
Shares outstanding 94.4M
Float 85.99M
Shares short 7.88M
% Held by insiders 0.03%
% Held by institutions 0.98%
Average volume (10 days) 1.5M
Average volume (90 days) 2.22M
Price summary
52-Week low 2.74
52-Week high 8.59
Beta 1.64
50-Day moving average 4.14
200-Day moving average 4.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 26 Mar 2009
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.14%
Operating margin -0.12%
Operational effectiveness
Return on assets -0.18%
Return on equity -0.33%
Income Statement
Revenue (ttm) 557M
Revenue per share (ttm) 8.51
Quarterly revenue growth (yoy) -0.21%
Gross profit (ttm) 379.1M
EBITDA -111.9M
Net income to common (ttm) -230M
Diluted EPS (ttm) -1.19
Quarterly earnings growth (yoy) 0.02%
Balance Sheet
Total cash (mrq) 150.7M
Total cash per share (mrq) 1.22
Total debt (mrq) 211.5M
Total Debt/Equity (mrq) 0.69
Current ratio (mrq) 2.21%
Book value per share (mrq) 3.21
Cash Flow
Cash flow statement -26.2M
Levered free cash flow (LFCF) -46.06M
